# The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

> **NCT00001629** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 49 (—)

## Conditions studied

- Atherosclerosis
- Heart Failure, Congestive
- Hypertension
- Myocardial Infarction

## Interventions

- **DRUG:** Angiotensin II type 1 receptor antagonists

## Key facts

- **NCT ID:** NCT00001629
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 49 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001629, "The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00001629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*